1-20 of 80
Bijal D. Shah
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Retrospective Analysis of Minimal Residual Disease Testing By High Throughput Immunosequencing Versus High Sensitivity Flow Cytometry and qPCR in B-Lymphoblastic Leukemia

Omar Fathalla, Anwar Khan, Nagehan Pakasticali, Bijal D. Shah, Mohammad O Hussaini
Journal: Blood
Blood (2021) 138 (Supplement 1): 4476.
DOI: https://doi.org/10.1182/blood-2021-154383
Published: 2021
Journal Articles

A Single-Arm, Open-Label Phase 2 Pilot Study of Vyxeos (CPX-351) in Adults with Relapsed or Refractory Acute Lymphoblastic Leukemia

Bijal D. Shah, Nicole Rozario, Elyce P. Turba, Celeste Bello, Julio C. Chavez, Lubomir Sokol, Jason Brayer, Jeffrey E. Lancet
Journal: Blood
Blood (2021) 138 (Supplement 1): 4399.
DOI: https://doi.org/10.1182/blood-2021-151936
Published: 2021
Journal Articles

A Phase 1 Study of XmAb18968, a CD3-CD38 Bispecific Antibody for the Treatment of Patients with Relapsed/Refractory Acute Leukemia and T Cell Lymphoblastic Lymphoma

Guru Subramanian Guru Murthy, Tyce J Kearl, Weiguo Cui, Bryon Johnson, Karin Hoffmeister, Aniko Szabo, Kazuhiro Aoki, Alexandra M. Harrington, Karen Carlson, Laura C. Michaelis, Lyndsey Runaas, Sameem Abedin, Adam S Duvall, Wendy Stock, Bijal D. Shah, Jessica Leonard, Keith W. Pratz, Selina M. Luger, Talha Badar, Arielle Baim, Shahriar Yaghoubi, Ehab L. Atallah
Journal: Blood
Blood (2021) 138 (Supplement 1): 4401.
DOI: https://doi.org/10.1182/blood-2021-149329
Published: 2021
Journal Articles

Trial in Progress: A Phase 2 Single Arm, Multicenter Trial to Evaluate the Efficacy of the BiTE ® Antibody Blinatumomab (Blincyto) and Vincristine Sulfate Liposomal Injection (Marqibo) in Adult Subjects with Relapsed/Refractory Philadelphia Negative CD19+ Acute Lymphoblastic Leukemia

David A Rizzieri, Jessica Leonard, Talha Badar, Franklin L. Chen, Bijal D. Shah, Zhiguo Li
Journal: Blood
Blood (2021) 138 (Supplement 1): 4404.
DOI: https://doi.org/10.1182/blood-2021-144548
Published: 2021
Journal Articles

The Comparison of Kte-X19 to Current Standards of Care: A Pre-Specified Synthetic Control Study Utilizing Individual Patient Level Data from Historic Clinical Trials (SCHOLAR-3)

Bijal D. Shah, Imi Faghmous, James Whitmore, Behzad Kharabi Masouleh, Hairong Xu
Journal: Blood
Blood (2021) 138 (Supplement 1): 3844.
DOI: https://doi.org/10.1182/blood-2021-146598
Published: 2021
Journal Articles

Primary Progression on Frontline Therapy for Diffuse Large B-Cell Lymphoma Is Associated with a Poor Outcome Despite Subsequent CD19 Targeted CAR T-Cell Therapy

Ariel Perez Perez, Grace Johnson, Kedar Patel, Brian Arciola, Anthony Wood, Christina A Bachmeier, Julio C. Chavez, Bijal D. Shah, Farhad Khimani, Taiga Nishihori, Aleksandr Lazaryan, Marco L. Davila, Rahul Mhaskar, Frederick L. Locke, Sameh Gaballa, Michael D. Jain
Journal: Blood
Blood (2021) 138 (Supplement 1): 3855.
DOI: https://doi.org/10.1182/blood-2021-150735
Published: 2021
Journal Articles

Upfront Targeted Tyrosine Kinase Inhibitor Therapy Improves Outcome in Patients with Myeloid/Lymphoid Neoplasms with Eosinophilia

Yumeng Zhang, Chuanyi M. Lu, Endi Wang, Lynh Nguyen, Marietya Lauw, Somedeb Ball, Ning C. Dong, Lynn C. Moscinski, Onyee Chan, Seongseok Yun, Lubomir Sokol, Bijal D. Shah, Jeffrey E. Lancet, Andrew T. Kuykendall, Eric Padron, Ling Zhang
Journal: Blood
Blood (2021) 138 (Supplement 1): 3658.
DOI: https://doi.org/10.1182/blood-2021-151654
Published: 2021
Journal Articles

Preliminary Safety and Efficacy of PBCAR0191, an Allogeneic 'Off-the-Shelf' CD19-Directed CAR-T for Patients with Relapsed/Refractory (R/R) CD19+ B-ALL

Nitin Jain, Hagop Kantarjian, Scott R. Solomon, Fiona He, Craig S. Sauter, Christopher R. Heery, Alan F. List, Mark C. Johnson, Yu Lou, Monika Vainorius, Koen van Besien, Adam J. Olszewski, Anthony S. Stein, Bijal D. Shah
Journal: Blood
Blood (2021) 138 (Supplement 1): 650.
DOI: https://doi.org/10.1182/blood-2021-153166
Published: 2021
Journal Articles

Brexucabtagene Autoleucel for Relapsed/Refractory Mantle Cell Lymphoma: Real World Experience from the US Lymphoma CAR T Consortium

Yucai Wang, Preetesh Jain, Frederick L. Locke, Javier Munoz, Matthew J. Maurer, Amer Beitinjaneh, Matthew J. Frank, Saurabh Dahiya, Joseph P. McGuirk, Miriam T. Jacobs, Andre H. Goy, Julie M. Vose, Brian T. Hill, Olalekan O. Oluwole, Abhinav Deol, Bijal D. Shah, Jonas Paludo, Trent Wang, Lazaros J. Lekakis, David B. Miklos, Aaron P. Rapoport, Armin Ghobadi, Sattva S. Neelapu, Yi Lin, Michael Wang, Michael D. Jain
Journal: Blood
Blood (2021) 138 (Supplement 1): 744.
DOI: https://doi.org/10.1182/blood-2021-147563
Published: 2021
Journal Articles

Allogeneic CAR-T PBCAR0191 with Intensified Lymphodepletion Is Highly Active in Patients with Relapsed/Refractory B-Cell Malignancies

Bijal D. Shah, Caron Jacobson, Scott R. Solomon, Nitin Jain, Mark C. Johnson, Monika Vainorius, Lou Yu, Christopher R. Heery, Alan F. List, Fiona He, Ran Reshef, Luke P. Akard, Craig S. Sauter, Adam J. Olszewski, Abhinav Deol, Koen van Besien
Journal: Blood
Blood (2021) 138 (Supplement 1): 302.
DOI: https://doi.org/10.1182/blood-2021-150609
Published: 2021
Journal Articles

Age-Related Clonal Hematopoiesis Is a Precursor for Adult Acute Lymphoblastic Leukemia

Caner Saygin, Todd C. Knepper, Alexandra E Rojek, Peng Wang, Jeremy Segal, Wendy Stock, Bijal D. Shah
Journal: Blood
Blood (2021) 138 (Supplement 1): 3477.
DOI: https://doi.org/10.1182/blood-2021-152807
Published: 2021
Journal Articles

Immunogenicity of Sars-Cov-2 mRNA 1273 Vaccine in Patients with Lymphoid Malignancies

Ning Dong, Akriti G Jain, Elaine S Tan, Somedeb Ball, Junmin Whiting, Sameh Gaballa, Leidy Isenalumhe, Celeste Bello, Hayder Saeed, Bijal D. Shah, Frederick L. Locke, Julio C. Chavez, Jeffrey E. Lancet, Lubomir Sokol, Javier Pinilla Ibarz, Anna Giuliano
Journal: Blood
Blood (2021) 138 (Supplement 1): 2504.
DOI: https://doi.org/10.1182/blood-2021-150465
Published: 2021
Journal Articles

Concurrent Monitoring of Peripheral Blood Circulating Tumor DNA and Circulating Tumor Cells in Relapsed/Refractory Follicular Lymphoma Patients Post Axicabtagene Ciloleucel, a Single Center Experience

Sameh Gaballa, Julio C. Chavez, Michael D. Jain, Meghan A Menges, Kayla M Reid, David Kaldas, Bijal D. Shah, Marco L. Davila, Frederick L. Locke
Journal: Blood
Blood (2021) 138 (Supplement 1): 2397.
DOI: https://doi.org/10.1182/blood-2021-149559
Published: 2021
Journal Articles

Lymphocyte Recovery Following Autologous Hematopoietic Stem Cell Transplant in Classical Hodgkin Lymphoma

Ashley Rose, Quinto J Gesiotto, Leidy Isenalumhe, Farhad Khimani, Hien D. Liu, Sameh Gaballa, Julio C. Chavez, Bijal D. Shah, Javier Pinilla Ibarz, Celeste Bello, Lubomir Sokol, Hayder Saeed
Journal: Blood
Blood (2021) 138 (Supplement 1): 2913.
DOI: https://doi.org/10.1182/blood-2021-150542
Published: 2021
Journal Articles

Real-World Bruton Tyrosine Kinase Inhibitor Treatment Patterns, Compliance, Costs, and Hospitalizations in Patients with Mantle Cell Lymphoma in the United States

Bijal D. Shah, Keri Yang, Sizhu Liu, Jai Sivanantham, Yasser Ali, Chris Casten, Swaroop Satya, Boxiong Tang
Journal: Blood
Blood (2021) 138 (Supplement 1): 3046.
DOI: https://doi.org/10.1182/blood-2021-148053
Published: 2021
Journal Articles

Change in Patients' Perceived Cognition Among Chimeric Antigen Receptor T-Cell Therapy Recipients at Day 360

Anna Barata, Aasha I. Hoogland, Anuhya Kommalapati, Jennifer M Logue, Kelly A. Hyland, Sarah L. Eisel, Brent J. Small, Taylor Welniak, Nathaly Irizarry-Arroyo, Yvelise Rodriguez, Reena Jayani, Margaret Booth-Jones, Laura B. Oswald, Brian D. Gonzalez, Kedar Kirtane, Michael D. Jain, Sepideh Mokhtari, Julio C. Chavez, Aleksandr Lazaryan, Bijal D. Shah, Frederick L. Locke, Heather S. L. Jim
Journal: Blood
Blood (2021) 138 (Supplement 1): 3052.
DOI: https://doi.org/10.1182/blood-2021-150838
Published: 2021
Journal Articles

KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results

Clinical Trials & Observations
Bijal D. Shah, Michael R. Bishop, Olalekan O. Oluwole, Aaron C. Logan, Maria R. Baer, William B. Donnellan, Kristen M. O’Dwyer, Houston Holmes, Martha L. Arellano, Armin Ghobadi, John M. Pagel, Yi Lin, Ryan D. Cassaday, Jae H. Park, Mehrdad Abedi, Januario E. Castro, Daniel J. DeAngelo, Adriana K. Malone, Raya Mawad, Gary J. Schiller, John M. Rossi, Adrian Bot, Tong Shen, Lovely Goyal, Rajul K. Jain, Remus Vezan, William G. Wierda
Journal: Blood
Blood (2021) 138 (1): 11–22.
DOI: https://doi.org/10.1182/blood.2020009098
Published: 2021
Includes: Supplemental data
Journal Articles

Targeting Kinome Reprogramming for Overcoming Ibrutinib-Resistance (IR) in Mantle Cell Lymphoma (MCL)

Xiaohong Zhao, MD PhD, Huijuan Jiang, MD, Michelle Wang, Tao Li, MD, Jing Gao, PhD, Tint Lwin, MD PhD, Yuan Ren, PhD, Eduardo Sotomayor, MD, Bijal D. Shah, MD, Jianguo Tao, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2651.
DOI: https://doi.org/10.1182/blood-2018-99-116756
Published: 2018
Journal Articles

Pharmacoproteomics Identifies PLK1 As Vulnerability for Aggressive B-Cell Lymphomas

Yuan Ren, PhD, Chengfeng Bi, MD PhD, Xiaohong Zhao, MD PhD, Tint Lwin, MD PhD, Wang Cheng, MD, Ji Yuan, Ariosto Siqueira Silva, PhD, Bijal D. Shah, MD, Bin Fang, PhD, Tao Li, John M. Koomen, PhD, Huijuan Jiang, MD, Julio C. Chavez, MD, Lan V. Pham, PhD, Praneeth Reddy Sudalagunta, PhD, Lixin Wan, Xuefeng Wang, PhD, William S. Dalton, PhD MD, Lynn C. Moscinski, MD, Kenneth H. Shain, MD PhD, Julie M. Vose, MD MBA, John Cleveland, PhD, Eduardo Sotomayor, MD, Kai Fu, MD PhD, Jianguo Tao, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2853.
DOI: https://doi.org/10.1182/blood-2018-99-118004
Published: 2018
Journal Articles

Long-Term Follow-up of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma

Michael Wang, MD, Simon Rule, MD, Pier Luigi Zinzani, MD, Andre Goy, MD, Olivier Casasnovas, MD, Stephen D. Smith, MD, Gandhi Damaj, MD PhD, Jeanette K. Doorduijn, MD PhD, Thierry Lamy, Franck Morschhauser, MD, Carlos Panizo, MD PhD, Bijal D. Shah, MD, Andrew Davies, Richard Eek, MBCHB, Jehan Dupuis, MD, Eric Jacobsen, MD, Arnon P. Kater, MD PhD, Steven LE Gouill, MD PhD, Lucie Oberic, MD, Tadeusz Robak, MD PhD, Richa Dua, PharmD, Melanie M. Frigault, PhD, Raquel Izumi, PhD, Dorothy Nguyen, MD PhD, Priti Patel, MD, Ming Yin, PhD, Wojciech Jurczak, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2876.
DOI: https://doi.org/10.1182/blood-2018-99-110327
Published: 2018